FDA.reportPublic FDA data

NDC 68071-3298-06 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68071-3298
Requested NDC
68071-3298-06
Package NDCs from labels
68071-3298-3, 68071-3298-6, 68071-3298-9, 68071-3298-06
Manufacturer
NuCare Pharmaceuticals, Inc.
Effective date
2024-07-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Doxazosin - NuCare Pharmaceuticals, Inc.NuCare Pharmaceuticals, Inc.2024-07-09HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
68071-3298-32023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-3298-3Doxazosin30 in 1 BOTTLETABLET304
68071-3298-6Doxazosin60 in 1 BOTTLETABLET604
68071-3298-9Doxazosin90 in 1 BOTTLETABLET904

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-3298DOXAZOSIN TABLET [NUCARE PHARMACEUTICALS, INC.]4Current NDC, Legacy NDC, 3 package rows20240711_505d3c4c-5506-72cc-e054-00144ff88e88.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 4 · 67 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions7aeaa0e1-136c-444d-b66c-7a5a96fb30222025-12-05Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
Doxazosin mesylateDOXAZOSIN MESYLATEAphena Pharma Solutions - Tennessee, LLC445dc831-1960-4b25-e063-6294a90a6efd2025-11-24Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEUpsher-Smith laboratories, LLCb5d1c604-ce3b-4973-845f-9db267a945cd2025-11-12Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepackd42d2691-f25d-4dfc-99d0-3286d71480a42025-10-13Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions57f4a953-ad23-4a44-9956-c48aa59271322025-10-02Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAmerican Health Packaging3f4dc1a7-05e6-41d7-908c-30ce2677d87b2025-09-17Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutionsb4c974ad-cbd6-4811-ab48-461e7ffa99f72025-09-17Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAphena Pharma Solutions - Tennessee, LLC3ab222b7-74cc-5343-e063-6294a90a96162025-07-24Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals, Inc.30b709d6-c438-c721-e063-6294a90abd612025-03-19Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
YVTYVT MICRODERMABRASION FACIAL SCRUBYVTYVT MICRODERMABRASION FACIAL SCRUBBeijing JUNGE Technology Co., Ltd.2f30fc45-42e2-c766-e063-6394a90a8d682025-02-28WarningsExact identifier
unii: OP1R32D61U
DoxazosinDOXAZOSINAphena Pharma Solutions - Tennessee, LLC2e5cd8cb-7d43-e7af-e063-6294a90a310e2025-02-17Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DOXAZOSINDOXAZOSINdirect rxb57cf33b-e0bd-54e9-e053-2a95a90a5a6a2025-01-17Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals,Inc.88efdfb0-710f-768a-e053-2995a90aede42024-12-17Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINZydus Lifesciences Limitedac889877-133c-4448-af5a-d77b3cbfe8782024-11-28Exact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEA-S Medication Solutions9b6170e7-814a-46ef-b068-cf3e6508d5e12024-10-21Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEAurobindo Pharma Limited93f2d724-5a54-4721-b04a-e46bc764607b2024-09-06Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepack8c0c0345-833b-4a3d-9081-da66b208d7502024-09-05Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepackef8b5534-5939-400a-ad5e-f9ceaefc40972024-09-05Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepackac4cd22b-2a03-47b6-9eed-550be278f17d2024-09-05Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAccord Healthcare Inc.2830533c-ccdf-4401-b19c-763eeb1bc0a72024-08-15Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.